310 Efficacy and safety of abrocitinib in biologic-exposed versus biologic-naïve patients with moderate-to-severe atopic dermatitis

Details

Language :

English

ISSN :

0022202X and 15231747

Volume :

142

Issue :

8, Number 8 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Investigative Dermatology

Publication Type :

Periodical

Accession number :

ejs61916420

Full Text :

https://doi.org/10.1016/j.jid.2022.05.318